1. Introduction {#sec1-ijerph-16-01899}
===============

According by WHO, the human immunodeficiency virus (HIV) is the virus that can destroy or impair immune system function and lead to acquired immunodeficiency syndrome (AIDS) which is known as the most advanced stages of HIV infection \[[@B1-ijerph-16-01899]\]. By the end of 2017, there were 36.9 million people living with HIV worldwide, with 1.8 million new infection cases and 940,000 deaths \[[@B2-ijerph-16-01899]\]. Therefore, HIV/AIDS is considered as a global health burden \[[@B3-ijerph-16-01899]\]. The ongoing HIV epidemic requires continued and novel strategies in order to address the biomedical and psychosocial nature of the disease \[[@B4-ijerph-16-01899],[@B5-ijerph-16-01899]\].

Since its identification nearly 40 years ago \[[@B6-ijerph-16-01899],[@B7-ijerph-16-01899]\], one of the toughest challenges faced by people living with HIV (PLWH) is social stigma and discrimination \[[@B8-ijerph-16-01899]\]. According to the sociologist Erving Goffman, stigma can be defined as "an attribute that links a person to an undesirable stereotype, leading other people to reduce the bearer from a whole and usual person to a tainted, discounted one" \[[@B9-ijerph-16-01899]\]. Stigma and discrimination are not only fuel the spread of epidemics, but also impact patients in their responses and living with HIV/AIDS by social isolation, stress and emotional coping, and denial of social and economic resources \[[@B5-ijerph-16-01899],[@B10-ijerph-16-01899]\]. Despite much intensive understandings of HIV and advancements in HIV treatment, studies have recorded HIV stigma and discrimination within interpersonal, community, and healthcare environments. Discriminatory attitudes, HIV testing without consent, refusal of care and treatment, and confidentiality violation have been observed in a large number of healthcare workers \[[@B11-ijerph-16-01899],[@B12-ijerph-16-01899],[@B13-ijerph-16-01899]\]. A study by Wagner also reported high levels of discrimination and even overlapping stigmas held by health care providers in such a developed country as Canada \[[@B14-ijerph-16-01899]\].

Stigma and discrimination have affected PLWH's life in many ways, and most of them are detrimental. HIV-related stigma is often associated with psychological distress, such as shame \[[@B15-ijerph-16-01899]\], depression \[[@B16-ijerph-16-01899]\], anxiety \[[@B17-ijerph-16-01899],[@B18-ijerph-16-01899]\], suicidal ideation \[[@B19-ijerph-16-01899]\] and quality of life \[[@B20-ijerph-16-01899],[@B21-ijerph-16-01899],[@B22-ijerph-16-01899]\]. Furthermore, stigma towards PLWH in healthcare settings is considered one of the major barriers to optimal treatment. Numerous studies suggest that experiences of HIV-related stigma resulted in lower access to HIV treatment, low utilization of HIV care services, poorer antiretroviral therapy (ART) adherence, and thus poorer treatment outcomes \[[@B12-ijerph-16-01899],[@B13-ijerph-16-01899],[@B23-ijerph-16-01899]\].

Although a growing body of literature has expressed the interest in this topic, most research has focused on general issues related to HIV stigma. Marshall et al. measured the HIV-related discrimination among healthcare providers \[[@B13-ijerph-16-01899]\]. A systematic review conducted by Rueda et al. examined the associations between HIV-related stigma and health outcomes in PLWH \[[@B24-ijerph-16-01899]\]. These and other reviews provided a summary of research in this field, however, did not fully describe the trends in research and intervention designs as well as the emergence of research approaches over time. Quantifying the growth in studies and usage, which is defined as the total downloads, as well as characterizing research domains are beneficial for informing priority settings and programming, especially in a particular context. This study aims to measure the international growth in specific research interests by evaluating the tendency of research topics of published articles over time and establishing a network of research collaborations based on published literature. We also delineated the development of research landscapes for factors associated with HIV stigma and discrimination among PLWH.

2. Materials and Methods {#sec2-ijerph-16-01899}
========================

2.1. Search Strategy {#sec2dot1-ijerph-16-01899}
--------------------

A cross-sectional study for HIV/AIDS bibliography analysis was designed based on the Web of Science database. The search query of keywords consisted of HIV; human-immunodeficiency-virus, AIDS, and acquired-immune-deficiency-syndrome. We selected two types of research paper, namely research articles and research reviews, and excluded other document types (e.g., books, book chapters or data papers). The language and publication date were also restricted. The publications in English until 2017 were chosen because this study was performed in the middle of 2018. Thus, the data produced in the first half of the year may not fully reflect the trend of the entire year. The second step was to select papers mentioning stigma and discrimination in the Abstracts or Titles.

2.2. Data Extraction {#sec2dot2-ijerph-16-01899}
--------------------

Data, including authors' names, the papers' titles, the journals' names, keywords, institutional affiliations, the frequency of citation, subject categories, and abstracts, were downloaded from the Web of Science database. In addition, the citation reports automatically created by the Web of Science were also downloaded. All data were converted to xlsm form (Microsoft Excel) for data checking of errors. In order to bring together the different names of an author, a process of standardization was carried out by two researchers ([Figure 1](#ijerph-16-01899-f001){ref-type="fig"}).

2.3. Data Analysis {#sec2dot3-ijerph-16-01899}
------------------

We analyzed data based on general characteristics (publication years, main categories, number of authors), keywords (co-occurrence keywords and most common keywords), citations, usages, and abstracts. After downloading and extracted data, we applied Macro, a programming code run on Excel, to calculate countries' citation, intra- and inter-country collaboration. The connection among countries sharing the co-authorships was illustrated by a network graph. The author keyword co-occurrence network and countries network were also created by VOSviewer (version 1.6.8, Center for Science and Technology, Leiden University, Leiden, the Netherlands). We applied exploratory factor analysis to identify research domains emerging from all contents of the abstracts; loadings of 0.4. Jaccard's similarity index was utilized to identify research topics or terms most frequently co-occurring with each other. It was defined as the size of the intersection divided by the size of the union of two sets of co-occurring terms. We created illustrations of the proximity values computed on all analyzed keywords using multidimensional scaling. In the map, a point represented a topic category, and the distances between pairs of items revealed to what extent those items appeared together. Colors represented the membership of specific items to different partitions created using hierarchical clustering. Stata software was used for statistical analyses. Analysis of each type of text data are presented as follows ([Table 1](#ijerph-16-01899-t001){ref-type="table"}):

3. Results {#sec3-ijerph-16-01899}
==========

3.1. Number of Published Items and Publication Trend {#sec3dot1-ijerph-16-01899}
----------------------------------------------------

The paper selection process is displayed in [Figure 1](#ijerph-16-01899-f001){ref-type="fig"}. Among 250,270 articles in 153 HIV related research areas, 5984 papers including the terms "stigma" or "discrimination" in the title or abstract were selected and analyzed.

The number of papers counted by study settings of 125 countries is presented in [Table 2](#ijerph-16-01899-t002){ref-type="table"}. The American population appears to be the most well-studied one with 406 cases, accounting for 14.26% of the total sample.

The increasing number of papers on discrimination towards people living with HIV/AIDS can be observed from [Table 3](#ijerph-16-01899-t003){ref-type="table"}. Throughout the last decade, the number of papers has been considerably grown and reached 633 articles in 2017, tripling that of 2007 and making up over 15% of total HIV/AIDS studies. Notably, the total usage of the last five years of 2003 is about 3--4 times higher compared to the previous years. Total citations and usage rates have also risen remarkably, especially from 2003. Particularly, in terms of mean use rate of the last five years, the figures for the years 2003 and 2013 were the largest throughout the research period.

3.2. Authors and Collaborations {#sec3dot2-ijerph-16-01899}
-------------------------------

The global network among 97 countries having co-authorship of selected papers is illustrated in [Figure 2](#ijerph-16-01899-f002){ref-type="fig"}. The figure was constructed by counting the co-occurrence of different countries in the authors' affiliations, and clustering them into groups of countries with similar level of co-authorship with other countries. The size of nodes is proportional to the contribution to the number of papers and the thickness of lines represents the percentage of the number of collaboration. These countries have been classified into 9 clusters of at least five countries depending on their level of international collaborations. Each color indicates a level of international co-authorship. Apart from leading nations in global HIV initiatives, such as the United States or the United Kingdom, regional neighbors or countries sharing the same languages tend to have similar levels of international co-authorship.

3.3. Keywords and Research Domains {#sec3dot3-ijerph-16-01899}
----------------------------------

[Figure 3](#ijerph-16-01899-f003){ref-type="fig"} reveals the principal components of the keywords structure with the most frequent groups of terms. There were five major clusters emerging from 406 most frequent keywords co-occurrence of 20 times and higher. Cluster 1 (red) refers to prevention of HIV transmissions through sex or blood in particular subjects, including transgender, bisexual men, female sex workers and injecting drug users, in America, India, and Thailand. Cluster 2 (green) focuses on HIV medication adherence and associated matters in several African countries. Cluster 3 (yellow) reveals social issues relating to the mental health of young adults and homosexuals in the United States. Cluster 4 (blue) describes experiences of families having members with HIV-related chronic illnesses, while cluster 5 (purple) mentions two types of HIV/AIDS stigma, which are self-stigma and perceived stigma.

The top 50 research domains and keywords emerged from the exploratory factor analysis of all abstracts' contents are listed in [Table 4](#ijerph-16-01899-t004){ref-type="table"}. Men who have sex with men, care providers, and female sex workers were the top three domains attracting greatest interest and each accounted for nearly half of total cases. Stigma and discrimination relating research domains focused on risk behaviors, clinical and quality of life outcomes, and HIV-related services uptake. Contextual factors were only found in domain \# 32, which was cultural beliefs.

Exploratory factor analysis of abstracts' contents also emerged co-occurrence of most frequent topics ([Figure 4](#ijerph-16-01899-f004){ref-type="fig"}). A wide range of topics, such as outcomes of interventions, treatment and prevention, the role of social support and services, sexual transmission, and impact of discrimination and stigma, are specified in green nodes. Red nodes mention physical, psychological and social problems of people living with HIV/AIDS in general, whereas cluster in cobalt blue focuses on cross-sectional studies of the LGBT population. Brown cluster reveals the literature review of national policies and evidence of this epidemic. The remaining scatters on the right of the figure includes various issues. HIV testing and counseling, stigmatization of people living with HIV, vaccination and HIV-associated chronic diseases, for example, are the major concerns.

[Table 5](#ijerph-16-01899-t005){ref-type="table"} presents the most cited papers discussing interventions and trials related to stigma and HIV/AIDS. It depicts that the interests and preferences of the research community to approach stigma and discrimination include two main areas: (1) contextual factors including social, cultural, psycho-behaviors, gender, family and community and (2) the implementation of HIV vaccine trial.

4. Discussion {#sec4-ijerph-16-01899}
=============

This study reveals that the quantity and impacts, which are indicated by citations and usages, of publications on HIV-related stigma and discrimination have grown considerably, especially in recent years. Countries with large HIV populations, such as the United States of America, South Africa, China, India, and Uganda, possessed the highest number of empirical studies. Research landscapes related to stigma and discrimination include clinical, physical and mental health outcomes, risk behaviors of most-at-risk populations, and HIV-related services. We found a lack of empirical studies not only on social, cultural, and economic contexts but also on the design of specific interventions for particular contextual factors.

Findings from this study were in line with previous reviews in terms of factors associated with HIV-related stigma and discrimination. Previously, Sweileh published a review of 2509 papers relating to stigma and HIV/AIDS based on data obtained from Scopus database \[[@B25-ijerph-16-01899]\]. Nevertheless, the prior review simply focused on the bibliometric analysis without intensively examining research contents and scopes of the papers involved. Although similar trends in research growth and other bibliometric features were found in this research, since we quantified the factors associated with stigma and discrimination against HIV/AIDS patients and classified these factors into differential clusters, this study has enriched the understanding of current empirical research about stigma and discrimination and may help guide future studies. Specifically, media communication should expand the reach of existing interventions against the stigma of people living with HIV/AIDS. In addition, for designing interventions to reduce stigma, important context- and culture-specific factors should be incorporated into the characterization of causes of stigma. By precisely quantifying the frequency of research growth, we have incorporated a system-thinking perspective into the insights into HIV-related stigma and discrimination and have identified gaps, especially, about contextual factors, in the literature.

This study has several implications for improving HIV prevention, care, and treatment. It highlights a strong correlation between stigma and most at-risk populations, such as drug users, men who have sex with men and sex workers. In addition, as it is critical to eradicate stigma and discrimination in order to improve the access and utilization of HIV-related services \[[@B24-ijerph-16-01899],[@B26-ijerph-16-01899]\], research on HIV-related stigma should focus more on characterizing contexts of the populations of interest, along with combining different approaches and intervention packages. An intervention, for instance, may incorporate with community-based and mass media communication to elevate its value and reduce discrimination within the population, hence, improve multiple outcomes such as mental health status, substance use, social isolation, and employment. Also, stigma and anticipated discrimination may affect patients' quality of life due to a number of features, including family context, neighborhood, and occupation. Particularly, social judgment and stigma are highly expressed in many developing countries, where HIV epidemics mainly exist in groups exhibiting specific behaviors, such as injecting drugs and being sex workers \[[@B26-ijerph-16-01899]\]. Addressing HIV-related stigma, therefore, requires concrete empirical evidence in different contexts, which might characterize its associated factors and indicate potential effects of the interventions. Also emerged from these analyses was the association of health care services and stigma. In many circumstances, patients disclose to and seek help from health workers regarding their risk behaviors and health status. Thus, sustaining stigma reduction counseling and integrating psycho-behavioral interventions into services for PLWH may make a significant contribution to the increase of service uses and reduction of stigma against HIV-positive individuals.

Although we introduced a novel approach in summarizing and analyzing the literature, some limitations should be acknowledged. First, only publications in English were selected for this study. Another limitation is that the involved databases were limited only to the Web of Science. Despite the fact that Web of Science contains a large proportion of the literature of HIV/AIDS research, it is probably not fully representative of all data. Using the WoS database for this analysis was, however, limited in its capacity to construct indicators to describe research development. For example, we could only use the total number of downloads and the mean rates of downloads for assessing the usage. Besides, the content analysis solely consisted of abstracts instead of full texts; and the construction of different types of articles was not fully addressed in this approach of analysis. Traditionally, bibliometric analysis only focuses on number of papers and keywords instead of involving screening of abstracts because it works with a large number of papers. We enhanced the validity of such analysis by incorporating content analysis and scrutiny of abstracts in processing data. Therefore, this modified bibliometric analysis is able to put forward a comprehensive overview of research trends as well as identify gaps in the literature of the association between HIV-related stigma and contextual factors.

5. Conclusions {#sec5-ijerph-16-01899}
==============

In conclusion, stigma and discrimination against patients with HIV/AIDS continues to be an urgent issue, given the epidemic's dynamic nature in the extended life-long treatment. Future research and intervention will require a more intensive understanding of the impact of context as well as addressing the psycho-behavioral and social aspects of HIV care and treatment.
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ijerph-16-01899-t001_Table 1

###### 

Type of data and analytical methods.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------
  Type of Data                           Unit of Analysis     Analytical Methods             Presentations of Results
  -------------------------------------- -------------------- ------------------------------ --------------------------------------------------------------------
  Key words, Countries                   Words                Frequency of co-occurrence     \(1\) Map of keywords clusters

  Abstracts                              Words                Exploratory factors analyses   \(2\) Top 50 constructed research domains\
                                                                                             (3) Clustering map of the landscapes constructed by these domains.

  Abstracts                              Papers               Latent Dirichlet Allocation    \(4\) 10 classifications of research topics

  WoS classification of research areas   WoS research areas   Frequency of co-occurrence     \(5\) Dendrogram of research disciplines (WoS classification)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------

ijerph-16-01899-t002_Table 2

###### 

Number of paper by study settings.

  \#   Country          Freq.   Percent   \#   Country                Freq.   Percent   \#    Country                    Freq.   Percent
  ---- ---------------- ------- --------- ---- ---------------------- ------- --------- ----- -------------------------- ------- ---------
  1    United States    406     14.26     42   Rwanda                 10      0.35      84    Sri Lanka                  3       0.11
  2    South Africa     380     13.34     43   Spain                  10      0.35      85    Tajikistan                 3       0.11
  3    China            230     8.08      44   New Zealand            9       0.32      86    Togo                       3       0.11
  4    India            177     6.21      45   Senegal                9       0.32      87    Trinidad and Tobago        3       0.11
  5    Uganda           127     4.46      46   Taiwan                 9       0.32      88    Turkey                     3       0.11
  6    Kenya            116     4.07      47   Burkina Faso           8       0.28      89    Albania                    2       0.07
  7    Canada           104     3.65      48   Georgia                8       0.28      90    Bolivia                    2       0.07
  8    Tanzania         82      2.88      49   Ukraine                8       0.28      91    Cuba                       2       0.07
  9    Australia        73      2.56      50   Argentina              7       0.25      92    Czech                      2       0.07
  10   Viet Nam         67      2.35      51   Chile                  7       0.25      93    Gabon                      2       0.07
  11   Ethiopia         59      2.07      52   Guatemala              7       0.25      94    Gambia                     2       0.07
  12   Thailand         50      1.76      53   Italy                  7       0.25      95    Hungary                    2       0.07
  13   Brazil           44      1.54      54   Lao                    7       0.25      96    Kazakhstan                 2       0.07
  14   Ghana            44      1.54      55   Pakistan               7       0.25      97    Libya                      2       0.07
  15   Malawi           44      1.54      56   Bangladesh             6       0.21      98    Madagascar                 2       0.07
  16   Botswana         43      1.51      57   Barbados               6       0.21      99    Mali                       2       0.07
  17   United Kingdom   43      1.51      58   Colombia               6       0.21      100   Philippines                2       0.07
  18   Zimbabwe         43      1.51      59   Greece                 6       0.21      101   Suriname                   2       0.07
  19   Zambia           40      1.40      60   Sudan                  6       0.21      102   Wallis and Futuna          2       0.07
  20   Ireland          31      1.09      61   Belgium                5       0.18      103   Afghanistan                1       0.04
  21   Japan            23      0.81      62   Estonia                5       0.18      104   Angola                     1       0.04
  22   Mexico           23      0.81      63   Germany                5       0.18      105   Benin                      1       0.04
  23   Indonesia        22      0.77      64   Singapore              5       0.18      106   Bulgaria                   1       0.04
  24   Peru             22      0.77      65   United Arab Emirates   5       0.18      107   Burundi                    1       0.04
  25   Hong Kong        21      0.74      66   Yemen                  5       0.18      108   Central African Republic   1       0.04
  26   Namibia          21      0.74      67   El Salvador            4       0.14      109   Cyprus                     1       0.04
  27   Puerto Rico      21      0.74      68   Myanmar                4       0.14      110   Denmark                    1       0.04
  28   Malaysia         20      0.70      69   Portugal               4       0.14      111   Fiji                       1       0.04
  29   Iran             19      0.67      70   Russian Federation     4       0.14      112   French Guiana              1       0.04
  30   Nepal            18      0.63      71   Saudi Arabia           4       0.14      113   Grenada                    1       0.04
  31   Swaziland        16      0.56      72   Switzerland            4       0.14      114   Guinea                     1       0.04
  32   France           15      0.53      73   Croatia                3       0.11      115   Jersey                     1       0.04
  33   Mozambique       15      0.53      74   Egypt                  3       0.11      116   Macedonia                  1       0.04
  34   Jamaica          14      0.49      75   Guyana                 3       0.11      117   Micronesia                 1       0.04
  35   Cambodia         13      0.46      76   Honduras               3       0.11      118   Mongolia                   1       0.04
  36   Netherlands      13      0.46      77   Israel                 3       0.11      119   Morocco                    1       0.04
  37   Cameroon         11      0.39      78   Jordan                 3       0.11      120   Romania                    1       0.04
  38   Haiti            11      0.39      79   Kyrgyzstan             3       0.11      121   Solomon Islands            1       0.04
  39   Sweden           11      0.39      80   Nicaragua              3       0.11      122   Somalia                    1       0.04
  40   Lebanon          10      0.35      81   Poland                 3       0.11      123   Timor-Leste                1       0.04
  41   Lesotho          10      0.35      82   Serbia                 3       0.11      124   Tunisia                    1       0.04
                                          83   Sierra Leone           3       0.11      125   Uruguay                    1       0.04

ijerph-16-01899-t003_Table 3

###### 

General characteristics of publications.

  Year Published   Total \# Papers   Total Citations   Mean Cite Rate Per Year   Total Usage Last 6 Month   Total Usage Last 5 Years   Mean Use Rate Last 6 Month   Mean Use Rate Last 5 Year
  ---------------- ----------------- ----------------- ------------------------- -------------------------- -------------------------- ---------------------------- ---------------------------
  2017             633               806               1.27                      1150                       3455                       1.82                         1.09
  2016             661               2418              1.83                      712                        5409                       1.08                         1.64
  2015             632               4208              2.22                      481                        5930                       0.76                         1.88
  2014             493               5691              2.89                      363                        5756                       0.74                         2.34
  2013             520               8340              3.21                      337                        7136                       0.65                         2.74
  2012             418               6992              2.79                      172                        4369                       0.41                         2.09
  2011             356               6544              2.63                      159                        3068                       0.45                         1.72
  2010             340               6818              2.51                      131                        2388                       0.39                         1.40
  2009             286               7486              2.91                      125                        2133                       0.44                         1.49
  2008             284               8846              3.11                      127                        1897                       0.45                         1.34
  2007             243               7669              2.87                      107                        1521                       0.44                         1.25
  2006             184               6523              2.95                      58                         1052                       0.32                         1.14
  2005             146               6606              3.48                      67                         920                        0.46                         1.26
  2004             98                4542              3.31                      43                         634                        0.44                         1.29
  2003             81                7844              6.46                      86                         1099                       1.06                         2.71
  2002             68                2874              2.64                      25                         284                        0.37                         0.84
  2001             59                3175              3.17                      18                         334                        0.31                         1.13
  2000             69                3491              2.81                      28                         395                        0.41                         1.14
  1999             53                2396              2.38                      12                         226                        0.23                         0.85
  1998             40                1021              1.28                      11                         123                        0.28                         0.62
  1997             54                3866              3.41                      14                         213                        0.26                         0.79
  1996             53                1704              1.46                      9                          159                        0.17                         0.60
  1995             46                2460              2.33                      12                         189                        0.26                         0.82
  1994             31                1776              2.39                      8                          132                        0.26                         0.85
  1993             26                960               1.48                      5                          69                         0.19                         0.53
  1992             24                1539              2.47                      4                          111                        0.17                         0.93
  1991             12                565               1.74                      2                          24                         0.17                         0.40

ijerph-16-01899-t004_Table 4

###### 

Top 50 research domains emerged from exploratory factor analysis of all abstracts' contents.

  No   Name                                    Keywords                                                                                         Eigenvalue   Freq.   \% Cases
  ---- --------------------------------------- ------------------------------------------------------------------------------------------------ ------------ ------- ----------
  1    Men (Msm; Sex Sexual)                   msm; men; sex; sexual; risk                                                                      4.71         6175    50.94%
  2    Care Providers                          providers; provider; service; care; services; healthcare                                         1.61         5107    48.18%
  3    Fsws; Female Sex                        fsws; female; workers; clients; work; sex                                                        1.75         3542    39.24%
  4    Sexual Partners                         partners; partner; sexual; disclosure; communication                                             1.28         3347    38.17%
  5    Antiretroviral; Therapy                 antiretroviral; therapy; adherence; medication; treatment; taking                                2.63         4236    37.58%
  6    Dna; Rt                                 dna; rt; viral; discrimination                                                                   1.92         2449    36.15%
  7    Testing                                 testing; vct; test; counselling; uptake; tested; counseling; confidentiality                     2.06         3227    31.50%
  8    Reduction Intervention                  intervention; trial; reduction; follow; control; reducing                                        2.27         2586    31.40%
  9    Gender; Transgender                     gender; transgender; women; identity                                                             1.29         2412    31.23%
  10   Depression and Anxiety; Psychological   anxiety; depression; psychological; distress; symptoms; mental; stress; psychosocial; physical   4.19         3187    28.76%
  11   Children; Parents                       children; parents; families; caregivers; family; affected                                        2.46         2544    27.82%
  12   Gay Men                                 gay; bisexual; men; identity                                                                     1.42         2156    25.20%
  13   Chronic Illness                         illness; chronic; disease; conditions                                                            2.48         1834    24.60%
  14   Scale Scores; Factor                    scale; factor; scores; developed; measures                                                       1.35         1771    23.16%
  15   General Population                      general; population                                                                              1.48         1522    21.77%
  16   Family Members                          members; family; network                                                                         1.28         1466    19.45%
  17   Coping Strategies                       coping; internalized; strategies                                                                 1.18         1262    18.63%
  18   Policy and Practice                     practice; implications; policy                                                                   1.18         1300    18.55%
  19   Substance Abuse                         abuse; substance; alcohol; mental; violence                                                      1.67         1517    18.37%
  20   South Africa                            africa; saharan; south                                                                           1.69         1745    17.06%
  21   Transmission (PMTCT)                    pmtct; mothers; transmission                                                                     1.63         1124    16.34%
  22   QoL; Life Quality                       qol; quality; life                                                                               1.5          1287    16.06%
  23   Youth; Adults and Adolescents           youth; adolescents; young; adults                                                                1.78         1181    15.74%
  24   Income Countries                        income; countries; global                                                                        3.09         1140    15.54%
  25   Human Immunodeficiency                  immunodeficiency; human                                                                          1.39         1460    14.97%
  26   Behavior                                behavior; behaviors                                                                              1.15         951     13.52%
  27   Staff Training                          staff; management; training                                                                      1.19         923     13.49%
  28   Sexually Transmitted                    transmitted; sexually; infections; sti                                                           2.11         1384    12.77%
  29   Drug Users                              users; drug                                                                                      1.45         968     12.63%
  30   Black; States                           black; states; american                                                                          1.25         805     11.75%
  31   Majority                                majority; respondents                                                                            1.27         753     11.66%
  32   Cultural Beliefs                        beliefs; cultural                                                                                1.24         750     11.33%
  33   Association of Nurses                   nurses; plwh; association                                                                        1.44         762     11.25%
  34   Demographic Characteristics             characteristics; demographic                                                                     1.38         743     10.51%
  35   Urban and Rural                         rural; urban                                                                                     1.31         751     10.46%
  36   Counselling                             counselling programme; programmes;                                                               1.81         737     10.16%
  37   Structural                              structural                                                                                       1.14         514     8.59%
  38   Vaccine Trial                           vaccine; trial; participation                                                                    1.38         567     8.19%
  39   Order                                   order                                                                                            1.25         421     7.04%
  40   Common                                  common                                                                                           1.16         420     7.02%
  41   Prep                                    prep; exposure                                                                                   1.54         365     5.06%
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